No images? Click here Bimonthly News Update PDFNJ will be hosting a FREE webinar this Thursday at 11am - "Marijuana in the NJ Workplace: A Focus on Workers' Compensation". This webinar is open to any NJ business, so we strongly encourage you to share this information with business associates. If you have any questions, please contact Bill Lillis, Drug-Free Workplace Coordinator, at bill@drugfreenj.org or 862-253-6808. The NJ Cannabis Regulatory, Enforcement Assistance and Marketplace Modernization Act was signed into law by Governor Murphy on February 22, 2021, thereby legalizing recreational use of marijuana by adults 21 and over. The Partnership for a Drug-Free New Jersey will continue to keep members updated on this important issue. Our tool kit is currently undergoing revision to provide updated information on policies and procedures related to the law to assist you in maintaining a healthy, safe and drug-free workplace. Further revision will occur in the months ahead should the Cannabis Regulatory Commission sets forth additional protocols for employers. The next “Marijuana in the NJ Workplace” webinar will focus on medical marijuana and workers’ compensation. Register here and invite your business associates to attend. On February 22, 2021, New Jersey Governor Phil Murphy signed into law the New Jersey Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization Act (CREAMMA). “We are disappointed that the enabling legislation signed today to create an adult-use cannabis market falls short on allowing businesses to effectively maintain drug-free workplaces, as they are essential for certain safety occupations.” Gov. Phil Murphy has announced his last picks to serve on the Cannabis Regulatory Commission, completing the panel that will undertake the job of regulating the legal marijuana industry and licensing new dispensaries and growers Gov. Murphy signed three laws that will legalize marijuana in New Jersey and immediately put an end to arrests Monday, but for some, another question lingers Occasionally in the forefront of public attention since the COVID-19 crisis began has been America’s continuing challenge of dealing with the abuse of psychoactive drugs. On Jan. 28, the New York State Appellate Division, First Department, issued a decision with potentially significant implications for employers confronted with their employees’ use of medical marijuana. More than one-third of business leaders say ensuring a safe workplace will be more challenging over the next 12 months. A recent study links cannabis legalization with lower workers' compensation expense, both in terms of frequency and size of claims, at least among older workers, according to MarketWatch. Click the button below to receive your complimentary updates and become a Drugs Don't Work in NJ member We encourage you to share this bimonthly news update with your colleagues and business associates to stay informed on the issues regarding establishing and maintaining a drug-free workplace. |